Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 12, 2012 - Issue 5
Submit an article Journal homepage
70
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Possible role of nicotine for the treatment of mild cognitive impairment

Sungwon Roh Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
&
A Eden Evins Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. [email protected]
Pages 531-533 | Published online: 09 Jan 2014

References

  • Gauthier S, Reisberg B, Zaudig M et al. Mild cognitive impairment. Lancet367(9518), 1262–1270 (2006).
  • Petersen RC. Mild cognitive impairment as a diagnostic entity. J. Intern. Med.256(3), 183–194 (2004).
  • Winblad B, Palmer K, Kivipelto M et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med.256(3), 240–246 (2004).
  • Luck T, Luppa M, Briel S, Riedel-Heller SG. Incidence of mild cognitive impairment: a systematic review. Dement. Geriatr. Cogn. Disord.29(2), 164–175 (2010).
  • Roberts RO, Geda YE, Knopman DS et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic study of aging. Neurology78(5), 342–351 (2012).
  • Roberts JS, Karlawish JH, Uhlmann WR, Petersen RC, Green RC. Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members. Neurology75(5), 425–431 (2010).
  • Weinstein AM, Barton C, Ross L, Kramer JH, Yaffe K. Treatment practices of mild cognitive impairment in California Alzheimer’s Disease Centers. J. Am. Geriatr. Soc.57(4), 686–690 (2009).
  • Jack CR Jr, Petersen RC, Grundman M et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol. Aging29(9), 1285–1295 (2008).
  • Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med.352(23), 2379–2388 (2005).
  • Feldman H, Scheltens P, Scarpini E et al. Behavioral symptoms in mild cognitive impairment. Neurology62(7), 1199–1201 (2004).
  • Thal LJ, Ferris SH, Kirby L et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology30(6), 1204–1215 (2005).
  • Di Matteo V, Pierucci M, Di Giovanni G, Benigno A, Esposito E. The neurobiological bases for the pharmacotherapy of nicotine addiction. Curr. Pharm. Des.13(12), 1269–1284 (2007).
  • Levin ED, Rezvani AH. Development of nicotinic drug therapy for cognitive disorders. Eur. J. Pharmacol.393(1–3), 141–146 (2000).
  • White HK, Levin ED. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease. Psychopharmacology (Berl.)143(2), 158–165 (1999).
  • Barr RS, Culhane MA, Jubelt LE et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology33(3), 480–490 (2008).
  • Levin ED, Conners CK, Sparrow E et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl.)123(1), 55–63 (1996).
  • Potter AS, Newhouse PA. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol. Biochem. Behav.88(4), 407–417 (2008).
  • Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol. Psychiatry49(3), 258–267 (2001).
  • Newhouse P, Kellar K, Aisen P et al. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology78(2), 91–101 (2012).
  • Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch. Neurol.58(12), 1985–1992 (2001).
  • Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl.)210(4), 453–469 (2010).
  • Sauer J, Wastell DG, Hockey GR, Earle F. Performance in a complex multiple-task environment during a laboratory-based simulation of occasional night work. Hum. Factors45(4), 657–669 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.